XML 43 R37.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Computation of basic and diluted weighted average shares outstanding and associated net income (loss) per common share

The following table sets forth the computation of basic and diluted weighted average common shares outstanding and associated net income (loss) per common share attributable to Bruker Corporation common shareholders (in millions, except per share amounts):

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Net (loss) income attributable to Bruker Corporation

 

$

(59.6

)

 

$

40.9

 

 

$

(34.6

)

 

$

99.4

 

Dividends on Series A Mandatory Convertible Preferred Stock

 

 

2.8

 

 

 

 

 

2.8

 

 

 

Net (loss) income attributable to Burker Corporation common shareholders

 

$

(62.4

)

 

$

40.9

 

 

$

(37.4

)

 

$

99.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - basic

 

 

151.8

 

 

 

151.5

 

 

 

151.7

 

 

 

148.1

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Stock options, restricted stock units, and employee stock purchase plan

 

 

 

 

 

0.5

 

 

 

 

 

 

0.6

 

Series A Mandatory Convertible Preferred Stock

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - diluted

 

 

151.8

 

 

 

152.0

 

 

 

151.7

 

 

 

148.7

 

Net (loss) income per common share attributable to Bruker Corporation common shareholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.41

)

 

$

0.27

 

 

$

(0.25

)

 

$

0.67

 

Diluted

 

$

(0.41

)

 

$

0.27

 

 

$

(0.25

)

 

$

0.67

 

Schedule of common share equivalents have been excluded from the computation of diluted weighted-average common shares outstanding, as their effect would have been anti-dilutive

The following common share equivalents have been excluded from the computation of diluted weighted average common shares outstanding, as their effect would have been anti-dilutive (amounts in millions of shares):

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Stock options, restricted stock units, and employee stock purchase plan

 

 

1.3

 

 

 

0.3

 

 

 

1.3

 

 

 

0.3

 

Series A Mandatory Convertible Preferred Stock

 

 

5.4

 

 

 

 

 

 

1.8